Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib and Abl/Lyn inhibitor INNO‐406 in newly established K562 variants with <i>BCR‐ABL</i> gene amplificationKoji Morinaga, Takanori Ueda|International Journal of Cancer|2008Cited by 40